Skip To Main Content
Pasoon Hellamand on Muck Rack

Pasoon Hellamand

As seen in: Wiley Online Library
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Pasoon

Contact Pasoon, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Sex differences in the effectiveness of first-line tumour necrosis factor inhibitors in axial spondyloarthritis: results from the EuroSpA Research Collaboration Network

|
By Pasoon Hellamand, Lykke Midtbøll Ørnbjerg, Thomas Klausch, Michael T Nurmohamed
| bmj.com
Discussion This study is the first to quantify sex differences in treatment response and retention rates from axSpA patients initiating their first TNFi among 15 European countries, including data from over 27 000 patients. We observed substantially reduced treatment effectiveness in women compared with men. At 6 months, the probability of having ASDAS-CRP CII was 19% lower in women than men.
Open in Who Shared Issue with article?

Sex differences in the effectiveness of first‐line tumor necrosis factor inhibitors in psoriatic arthritis; results from the EuroSpA Research Collaboration Network

|
By Pasoon Hellamand, Lykke M. Ørnbjerg, Rigshospitalet Glostrup Denmark, Thomas Klausch
| Wiley Online Library Verified
Supporting Information Filename Description art42744-sup-0001-Disclosureform.pdfPDF document, 6.3 MB Disclosure Form art42744-sup-0002-Supinfo.pdfPDF document, 537.9 KB Supporting Information S1
Open in Who Shared View Duplicates (10) Issue with article?
See all 2 articles